Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: a flexible platform technology

Fig. 2

Characterization of nanoparticles (NPs) and released encapsulants. a Scanning electron micrographs (scale bar—200 nm). b Hydrodynamic size (polydispersity index) and c Zeta potential of—Control NPs (Blank), LPS encapsulated NPs, IpaB44-310 encapsulated NPs and IpaC encapsulated NPs respectively. The NPs were dissolved and the released encapsulants were analyzed. d Silver staining of released LPS. e and f SDS PAGE of released IpaB44-310 and IpaC respectively (arrow heads pointing to bands). g Release of model antigen IpaB44-310 as a function of time

Back to article page